Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Duchenne moms say FDA documents ‘widen the divide’ between drugs by BioMarin, Sarepta
Duchenne moms say FDA documents ‘widen the divide’ between drugs by BioMarin, Sarepta
Duchenne moms say FDA documents ‘widen the divide’ between drugs by BioMarin, Sarepta
Submitted by
admin
on November 20, 2015 - 6:19pm
Source:
Bizjournals.com
News Tags:
Duchenne Muscular Dystrophy
FDA
eterplirsen
drisapersen
Biomarin
Sarepta Therapeutics
Headline:
Duchenne moms say FDA documents ‘widen the divide’ between drugs by BioMarin, Sarepta
Do Not Allow Advertisers to Use My Personal information
